2026 NPPES data Sleep Medicine (Otolaryngology) Physician NPI 1609894930 M.D.
Verify on CMS →

PAUL BELL, M.D.

Sleep Medicine (Otolaryngology) Physician in GARDEN CITY, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
628
Medicare Part D claims · 314 beneficiaries · Sleep Medicine (Otolaryngology) Physician avg: 543
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.2882/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$1.2K
55 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PAUL BELL, M.D. reported a CMS MIPS final score of 91.2882/100 — above the 83.1 national average — and filed 628 Medicare Part D claims in 2023.

91.2882/100
MIPS score · +8 vs avg
628
Part D claims, 2023
95%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PAUL BELL, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

PAUL BELL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PAUL BELL, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/17/2006

NPI 1609894930

Primary specialty

Sleep Medicine (Otolaryngology) Physician

Rare

98 US NPIs in this specialty

Medicare Part D claims

628 16% vs specialty avg

2023 prescription claims

Specialty avg: 543

MIPS final score

91.2882/100 8.188200000000009% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Sleep Medicine (Otolaryngology) Physician compares to other specialties among New York providers

New York providers

Sleep Medicine (Otolaryngology) Physician share within New York

1. Sleep Medicine (Otolaryngology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Sleep Medicine (Otolaryngology) Physician share within New York

Medicare quality performance — MIPS

PAUL BELL, M.D.'s 2023 MIPS final score plotted against the Sleep Medicine (Otolaryngology) Physician national average

High performer (top quartile)
MIPS Final Score
91.2882/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Sleep Medicine (Otolaryngology) Physician) — 91.2882/100 vs national avg 83.1

0%100%National avg83%91.3%
MIPS final score (Sleep Medicine (Otolaryngology) Physician) — 91.2882/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PAUL BELL, M.D. appears in the CMS NPPES registry as a Sleep Medicine (Otolaryngology) Physician provider holding M.D. credentials at 990 STEWART AVENUE, GARDEN CITY, NY, 11530, with a listed phone of (516) 739-3999. NPI 1609894930 was issued on 07/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BELL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 628 prescription claims written by this provider, covering 314 Medicare beneficiaries and totaling roughly $124K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2882/100 for the 2023 performance year (Quality 84.1603), compared with the national average of 83.1.

Sleep Medicine (Otolaryngology) Physician is a narrow specialty nationwide, with 98 enrolled providers across 29 states and an average of 543 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

990 STEWART AVENUE
GARDEN CITY, NY 11530

Provider Details

NPI 1609894930
Specialty Sleep Medicine (Otolaryngology) Physician
Credentials M.D.
Gender Male
NPI Issued 07/17/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.2882
Final Score
Avg: 83.1
84.1603
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where PAUL BELL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ENT AND ALLERGY ASSOCIATES LLP
YONKERS, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PAUL BELL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to PAUL BELL, M.D.. To verify PAUL BELL, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

PAUL BELL, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 628 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

628
Total Claims
$124K
Total Drug Cost
314
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,063
Total Day Supply
26,072
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$99K
Generic Drug Cost
$25K
Antibiotic Claims
97

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.06
Gender Split
54% female / 46% male
Age Distribution
<65: 22, 65-74: 171, 75-84: 97, 85+: 24

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PAUL BELL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Fluticasone Propionate
91
Omeprazole
64
Ipratropium Bromide
61
Ofloxacin
47
Cefpodoxime Proxetil
42
Montelukast Sodium
31
Methylprednisolone
29
Mometasone Furoate
25
Pantoprazole Sodium
24
Prednisone
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Sleep Medicine (Otolaryngology) Physician Overview

How PAUL BELL, M.D. fits within the Sleep Medicine (Otolaryngology) Physician landscape nationally.

98
Sleep Medicine (Otolaryngology) Physician Providers in US
29
States with Sleep Medicine (Otolaryngology) Physician
543
Avg Claims per Provider

PAUL BELL, M.D.'s 628 claims are above the specialty average of 543.

Nearby Sleep Medicine (Otolaryngology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BELL.

Compare Sleep Medicine (Otolaryngology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PAUL BELL, M.D.'s specialty?
PAUL BELL, M.D. specializes in Sleep Medicine (Otolaryngology) Physician and practices in GARDEN CITY, New York. Credentials: M.D..
How much does PAUL BELL, M.D. prescribe under Medicare Part D?
In 2023, PAUL BELL, M.D. wrote 628 Medicare Part D claims totaling $124K in drug costs for 314 beneficiaries.
What is PAUL BELL, M.D.'s Medicare quality score?
PAUL BELL, M.D. has a CMS MIPS Final Score of 91.2882/100 (Quality: 84.1603). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is PAUL BELL, M.D. located?
PAUL BELL, M.D. is located at 990 STEWART AVENUE, GARDEN CITY, NY, 11530. Phone: (516) 739-3999.
What is PAUL BELL, M.D.'s NPI number?
PAUL BELL, M.D.'s National Provider Identifier (NPI) is 1609894930, issued on 07/17/2006.
Does PAUL BELL, M.D. prescribe more brand-name or generic drugs?
PAUL BELL, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $99K in brand drug costs.
How many Sleep Medicine (Otolaryngology) Physician providers are there in the US?
There are 98 Sleep Medicine (Otolaryngology) Physician providers across 29 states in the US. The average Sleep Medicine (Otolaryngology) Physician provider writes 543 Medicare Part D claims per year.
What drugs does PAUL BELL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, PAUL BELL, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Omeprazole, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PAUL BELL, M.D. accept Medicare?
PAUL BELL, M.D. appears in CMS Medicare data with 628 Part D claims and 314 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PAUL BELL, M.D.'s credentials?
PAUL BELL, M.D.'s NPI is 1609894930 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology